- Home
- HBNC vs LENZ Comparison
HBNC vs LENZ Comparison
Compare HBNC & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HBNC
- LENZ
- Stock Information
- Founded
- HBNC 1873
- LENZ 2019
- Country
- HBNC United States
- LENZ United States
- Employees
- HBNC N/A
- LENZ N/A
- Industry
- HBNC Major Banks
- LENZ Medicinal Chemicals and Botanical Products
- Sector
- HBNC Finance
- LENZ Health Care
- Exchange
- HBNC Nasdaq
- LENZ Nasdaq
- Market Cap
- HBNC 648.7M
- LENZ 664.5M
- IPO Year
- HBNC N/A
- LENZ 2021
- Fundamental
- Price
- HBNC $15.87
- LENZ $26.32
- Analyst Decision
- HBNC Hold
- LENZ Strong Buy
- Analyst Count
- HBNC 3
- LENZ 6
- Target Price
- HBNC $15.33
- LENZ $35.40
- AVG Volume (30 Days)
- HBNC 169.0K
- LENZ 181.9K
- Earning Date
- HBNC 10-23-2024
- LENZ 08-14-2024
- Dividend Yield
- HBNC 4.10%
- LENZ N/A
- EPS Growth
- HBNC N/A
- LENZ N/A
- EPS
- HBNC 0.43
- LENZ N/A
- Revenue
- HBNC $179,998,000.00
- LENZ N/A
- Revenue This Year
- HBNC N/A
- LENZ N/A
- Revenue Next Year
- HBNC $7.84
- LENZ N/A
- P/E Ratio
- HBNC $36.11
- LENZ N/A
- Revenue Growth
- HBNC N/A
- LENZ N/A
- 52 Week Low
- HBNC $9.22
- LENZ $2.01
- 52 Week High
- HBNC $16.64
- LENZ $27.81
- Technical
- Relative Strength Index (RSI)
- HBNC 60.42
- LENZ 60.81
- Support Level
- HBNC $14.44
- LENZ $23.16
- Resistance Level
- HBNC $16.05
- LENZ $27.81
- Average True Range (ATR)
- HBNC 0.40
- LENZ 1.80
- MACD
- HBNC 0.11
- LENZ 0.34
- Stochastic Oscillator
- HBNC 88.82
- LENZ 75.41
About HBNC Horizon Bancorp Inc.
Horizon Bancorp (IN) is a United States-based holding company providing banking services. It is engaged in providing commercial and retail banking services, corporate and individual trust and agency services, and other services incident to banking. The company also provides commercial loans, real estate loans, mortgage warehouse loans, consumer loans, and other credit facilities. The company has one principal business segment, commercial banking.
About LENZ LENZ Therapeutics Inc. Common Stock
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing innovative therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.